Abstract
Introduction Sickle cell disease (SCD) is the most prevalent monogenic disorder resulting from a mutation in the b-globin gene. Among its severe and multi-system complications, the cerebral vasculopathy (CV) generally occurring during childhood, is responsible for ischemic stroke, making SCD the first etiology of stroke in children and young adults (Guerriero RM, 2019, Ohene-Frempong K 1998).
SCD-related overt strokes are typically due to large-artery stenosis of carotid siphon. This stenosis is preceded by a high intracranial arterial velocity on transcranial Doppler (> 200 cm/s) (Adams RJ 1992). We hypothesis that the high flow rate and carotid geometry in small SCD children could lead to pathological velocities apparition and promote platelet secretion of pro-fibrotic factors. Thus, a 3D patient-specific vessel model enables to study the physiopathology of CV development. In this study, by developing an in sillico and in vitro personalized 3D carotid model we aim to evaluate impact of carotid geometry on the apparition of pathological intracranial velocities and the platelet secretion of pro-fibrotic factors.
Materials and methodsMathematical modelling of internal carotid and vascular flow
The internal carotid artery (ICA) with its terminal branches, anterior cerebral arterial (ACA) and middle cerebral arterial (MCA), was segmented from magnetic resonance angiography images for 4 SCD children < 5 years old (UF), 3 SCD children > 5 years old (OF) and 1 SCD adult (AD) on both sides. Blood flow was modelled using the 3D Navier-Stokes equations, assuming that blood is an incompressible Newtonian fluid. Pulsatile flow was assigned as an inlet boundary condition with mean flow rates varying from 5 to 15 mL/s which reflect the range of flow rates observed in SCD patients. TMMV and Dean number were calculated over five regions of interest, as shown in Fig 1A.
3D printing internal carotid
Segmented internal carotid arteries of an UF and an AD SCD patient were printed using stereolithography 3D printing.
Flow experiments in 3D printed carotid with platelet concentrates
Fresh apheresis platelet concentrates (APC) from 5 healthy donors were perfused in flow system containing either 3D-printed UF or AD carotid at either low or high flow (8 ml/s or 16 ml/s respectively) for 30 minutes. Platelet secretion of soluble CD62P (sCD62P), TGF-b, and TSP-1 at 5 min, 15 and 30 min in the supernatants was measured by ELISA.
Results and discussionsMathematical modelling of internal carotid and vascular blood flow
Simulation results show that for any inlet flow rate from 5 to 15 ml/s, the TMMV calculated in younger SCD children tend to be higher than in older patients. Consequently, most UF patients reach pathological TMMV (>200 m/s) at lower inlet flow rates compared to older patients (Fig 1B). The pathological TMMV seem to appear firstly and mostly in the carotid siphon or post-siphon regions (Fig 1B). TMMV shows significant correlation with Dean number (R = 0.72, p-value= 1e-14), as shown in Fig 1C, indicating high flow rate, large curvature and small cross-sectional area of cerebral arteries are closely linked with high TMMV.
Platelet secretion of soluble factors in 3D-printed carotid
The high flow induces an important platelet secretion of the TGF-b, a pro-fibrotic factor with increasing trend in UF than in AD carotid and in a time dependent manner (Fig 1D). In contrast, compared to resting condition, a similar sCD62P level is observed in either AD or UF carotid at low and high flow suggesting the absence of platelet activation in flow conditions, leading to a negligible platelet release of TSP-1, an anti-angiogenic and major endogenous activator of TGF-β. These results suggest that UF carotid geometry could promote platelet secretion of TGFb which is accentuated by high TMMV independently with platelet activation.
Conclusions and perspectives This study performed in a 3D personalized carotid model has demonstrated that at high flow which are generally observed in UF SCD patients, these patients are more likely to reach the pathological intracranial arterial velocities and the platelet secretion of pro-fibrotic factors compared to AD patients, leading to their high risk of stroke. The measurement of other platelet factors and the evaluation of geometrical features such as diameter, tortuosity and curvature in stenosis formation are in progress. These results could allow to explain the CV development in SCD.
Disclosures
Bartolucci:JazzPharma: Consultancy; Fabre Foundation: Research Funding; Global Blood Therapeutics: Consultancy, Research Funding; Agios: Consultancy, Research Funding; Bluebird bio: Consultancy, Research Funding; Emmaus: Consultancy, Research Funding; Innovhem: Other: Co-founder; Hemanext Inc: Consultancy; Novartis: Consultancy, Research Funding; Roche: Consultancy; Addmedica: Consultancy, Research Funding.
Author notes
Asterisk with author names denotes non-ASH members.